This episode of the Future Space Economy series focuses on how space is shaping the future of medicine. Host Jeff Hill is joined by Eascra Biotech CEO and co-founder Mari Anne Snow and Jana Stoudemire, senior executive, Barrios Technologies, to discuss some exciting new developments in bringing medical and pharmaceutical research to space.

Eascra Biotech is a nanomedicine company that was selected for NASA's Igniting Innovation: Science in Space to Cure Disease on Earth program to study a new application for their Janus Base Nanoparticles (JBNps) on the ISS. The program just launched to the ISS this past May. Snow talks about what they've learned about the ISS mission and how the space industry can better communicate the value of space as a research environment for the pharmaceutical industry.

Stoudemire is working to establish a new business at Barrios Technologies supporting the development of economically sustainable and profitable uses of space. After a career in pharma, biotech and medical devices, Stoudemire transitioned to lead life science research in microgravity as part of the team managing the International Space Station U.S. National Laboratory, and roles with Space Tango and Axiom Space.

This episode is part of the Future Space Economy webcast series, sponsored by MDA Space.